NEW HAVEN, Conn., July 10, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Milind Deshpande, Ph.D., President of Research and Development, and Chief Scientific Officer of Achillion, will present a corporate overview at the JMP Securities Healthcare Conference 2012. The presentation will take place at The Peninsula Hotel in New York, NY on Friday, July 13, 2012 at 9:30 a.m. EDT.
